Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 277 to 278 of 278 entries
Sorted by: Best Match Show Resources per page
Utilization of anti-factor Xa levels to guide reversal of oral factor Xa inhibitors in the emergency department.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Zepeski AE, Faine BA, Merrill AE, Sutamtewagul G, Bhagavathi S.
PMID: 34363457
Am J Health Syst Pharm. 2021 Aug 07; doi: 10.1093/ajhp/zxab326. Epub 2021 Aug 07.

DISCLAIMER: In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before...

Cite
Zepeski AE, Faine BA, Merrill AE, et al. Utilization of anti-factor Xa levels to guide reversal of oral factor Xa inhibitors in the emergency department. Am J Health Syst Pharm. 2021;doi: 10.1093/ajhp/zxab326.
Zepeski, A. E., Faine, B. A., Merrill, A. E., Sutamtewagul, G., & Bhagavathi, S. (2021). Utilization of anti-factor Xa levels to guide reversal of oral factor Xa inhibitors in the emergency department. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, . https://doi.org/10.1093/ajhp/zxab326
Zepeski, Anne E, et al. "Utilization of anti-factor Xa levels to guide reversal of oral factor Xa inhibitors in the emergency department." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. (2021). doi: https://doi.org/10.1093/ajhp/zxab326
Zepeski AE, Faine BA, Merrill AE, Sutamtewagul G, Bhagavathi S. Utilization of anti-factor Xa levels to guide reversal of oral factor Xa inhibitors in the emergency department. Am J Health Syst Pharm. 2021 Aug 07; doi: 10.1093/ajhp/zxab326. Epub 2021 Aug 07. PMID: 34363457; PMCID: PMC8385943.
Copy Download .nbib Format: NLM
Lymphadenectomy in gallbladder adenocarcinoma: Are we doing enough?.

American journal of surgery

Papageorge MV, de Geus SWL, Woods AP, Ng SC, Drake FT, Merrill A, Cassidy MR, McAneny D, Tseng JF, Sachs TE.
PMID: 34972539
Am J Surg. 2021 Dec 24; doi: 10.1016/j.amjsurg.2021.12.028. Epub 2021 Dec 24.

BACKGROUND: Current AJCC guidelines recommend evaluating ≥6 lymph nodes during gallbladder cancer resection but real world data suggest this is rarely achieved. We evaluated the extent of lymphadenectomy and survival among patients with gallbladder adenocarcinoma.METHODS: Patients with resected pT1b-T3...

Cite
Papageorge MV, de Geus SWL, Woods AP, et al. Lymphadenectomy in gallbladder adenocarcinoma: Are we doing enough?. Am J Surg. 2021;doi: 10.1016/j.amjsurg.2021.12.028.
Papageorge, M. V., de Geus, S. W. L., Woods, A. P., Ng, S. C., Drake, F. T., Merrill, A., Cassidy, M. R., McAneny, D., Tseng, J. F., & Sachs, T. E. (2021). Lymphadenectomy in gallbladder adenocarcinoma: Are we doing enough?. American journal of surgery, . https://doi.org/10.1016/j.amjsurg.2021.12.028
Papageorge, Marianna V, et al. "Lymphadenectomy in gallbladder adenocarcinoma: Are we doing enough?." American journal of surgery vol. (2021). doi: https://doi.org/10.1016/j.amjsurg.2021.12.028
Papageorge MV, de Geus SWL, Woods AP, Ng SC, Drake FT, Merrill A, Cassidy MR, McAneny D, Tseng JF, Sachs TE. Lymphadenectomy in gallbladder adenocarcinoma: Are we doing enough?. Am J Surg. 2021 Dec 24; doi: 10.1016/j.amjsurg.2021.12.028. Epub 2021 Dec 24. PMID: 34972539.
Copy Download .nbib Format: NLM
Showing 277 to 278 of 278 entries